EMMPRIN/CD147 is a co-receptor for VEGFR-2 in tumor angiogenesis: towards its inhibition.

Journal 2014

Authors: Khayati, F. / Fernández-Recio, Juan / Pérez, L. / Villoutreix, B. / Calvo, F. / Lebbe, C. / Menashi, S. / Mourah, S.

Publication: Fund. Clin. Pharm.

Volume / Pagination: 28 / 4-4

Paraules clau: EMMPRIN/CD147, targeted therapy, tumor angiogenesis, VEGFR-2